Orthopedic Reviews, 2016 · DOI: 10.4081/or.2016.6162 · Published: January 1, 2016
This study investigates the safety and effectiveness of injecting bone marrow concentrate during core decompression for femoral head osteonecrosis. The study involved 24 patients who were followed for two years to assess clinical and radiological outcomes. The results showed pain reduction and functional improvement, but no significant difference between those who received bone marrow concentrate and those who didn't.
Core decompression remains a viable option for treating ARCO II FHN.
The added benefit of bone marrow concentrate is questionable in the short term.
Longer-term studies with larger sample sizes are necessary to validate these results.